Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 18;59(12):e0165021.
doi: 10.1128/JCM.01650-21. Epub 2021 Sep 15.

Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening

Nadarra L Stokes  1 , Katelyn A Reed  1 , Elie F Berbari  2 , Sara Vetter  3 , Matthew J Binnicker  1
Affiliations

Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening

Nadarra L Stokes et al. J Clin Microbiol. .
No abstract available

Keywords: COVID-19; SARS-CoV-2; antigen; molecular.

PubMed Disclaimer

References

    1. Okoye NC, Barker AP, Curtis K, Orlandi RR, Snavely EA, Wright C, Hanson KE, Pearson LN. 2021. Performance characteristics of BinaxNOW COVID-19 antigen card for screening asymptomatic individuals in a university setting. J Clin Microbiol 59:e03282-20. doi:10.1128/JCM.03282-20. - DOI - PMC - PubMed
    1. Perchetti GA, Huang ML, Mills MG, Jerome KR, Greninger AL. 2021. Analytical sensitivity of the Abbott BinaxNOW COVID-19 Ag card. J Clin Microbiol 59:e02880-20. doi:10.1128/JCM.02880-20. - DOI - PMC - PubMed
    1. Pollock NR, Jacobs JR, Tran K, Cranston AE, Smith S, O’Kane CY, Roady TJ, Moran A, Scarry A, Carroll M, Volinsky L, Perez G, Patel P, Gabriel S, Lennon NJ, Madoff LC, Brown C, Smole SC. 2021. Performance and implementation evaluation of the Abbott BinaxNOW rapid antigen test in a high-throughput drive-through community testing site in Massachusetts. J Clin Microbiol 59:e00083-21. doi:10.1128/JCM.00083-21. - DOI - PMC - PubMed
    1. Prince-Guerra JL, Almendares O, Nolen LD, Gunn JKL, Dale AP, Buono SA, Deutsch-Feldman M, Suppiah S, Hao L, Zeng Y, Stevens VA, Knipe K, Pompey J, Atherstone C, Bui DP, Powell T, Tamin A, Harcourt JL, Shewmaker PL, Medrzycki M, Wong P, Jain S, Tejada-Strop A, Rogers S, Emery B, Wang H, Petway M, Bohannon C, Folster JM, MacNeil A, Salerno R, Kuhnert-Tallman W, Tate JE, Thornburg NJ, Kirking HL, Sheiban K, Kudrna J, Cullen T, Komatsu KK, Villanueva JM, Rose DA, Neatherlin JC, Anderson M, Rota PA, Honein MA, Bower WA. 2021. Evaluation of Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection at two community-based testing sites — Pima County, Arizona, November 3–17, 2020. Mmwr Morb Mortal Wkly Rep 70:100–105. doi:10.15585/mmwr.mm7003e3. - DOI - PMC - PubMed
    1. Shah MM, Salvatore PP, Ford L, Kamitani E, Whaley MJ, Mitchell K, Currie DW, Morgan CN, Segaloff HE, Lecher S, Somers T, Van Dyke ME, Bigouette JP, Delaney A, DaSilva J, O’Hegarty M, Boyle-Estheimer L, Abdirizak F, Karpathy SE, Meece J, Ivanic L, Goffard K, Gieryn D, Sterkel A, Bateman A, Kahrs J, Langolf K, Zochert T, Knight NW, Hsu CH, Kirking HL, Tate JE. 2021. Performance of Repeat BinaxNOW severe acute respiratory syndrome coronavirus 2 antigen testing in a community setting, Wisconsin, November 2020-December 2020. Clin Infect Dis 73:S54–S57. doi:10.1093/cid/ciab309. - DOI - PMC - PubMed

Substances